{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:06:51Z","timestamp":1780927611813,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Basic and Applied Basic Research Foundation Enterprise Joint Fund","award":["2023A1515220082"],"award-info":[{"award-number":["2023A1515220082"]}]},{"name":"Science, Technology and Innovation Commission of Shenzhen Municipality basic research funds","award":["JCYJ20230807115814030, JCYJ20220530142006015"],"award-info":[{"award-number":["JCYJ20230807115814030, JCYJ20220530142006015"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2023468, A2024364, A2022497"],"award-info":[{"award-number":["A2023468, A2024364, A2022497"]}]},{"name":"the Shenzhen Nanshan District Scientific Research Program","award":["NSZD2023035, NS20240014, NSZD2025005"],"award-info":[{"award-number":["NSZD2023035, NS20240014, NSZD2025005"]}]},{"name":"Municipal Financial Subsidy of Shenzhen Medical Key Discipline Construction Fund","award":["SZXK06162"],"award-info":[{"award-number":["SZXK06162"]}]},{"name":"Shenzhen Science and Technology Program","award":["KJZD20240903103500002"],"award-info":[{"award-number":["KJZD20240903103500002"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202303037"],"award-info":[{"award-number":["SZSM202303037"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04673-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:27:55Z","timestamp":1770298075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist"],"prefix":"10.1186","volume":"26","author":[{"given":"Congcong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuancheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"4673_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"G Cheung","year":"2021","unstructured":"Cheung G, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547\u201369.","journal-title":"Virulence"},{"issue":"1","key":"4673_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/cr100370n","volume":"111","author":"M Thoendel","year":"2011","unstructured":"Thoendel M, Kavanaugh JS, Flack CE, Horswill AR. Peptide signaling in the staphylococci. Chem Rev. 2011;111(1):117\u201351.","journal-title":"Chem Rev"},{"issue":"3","key":"4673_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VJ. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603\u201361.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"4673_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629\u201341.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"4673_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jgar.2013.03.002","volume":"1","author":"S Esposito","year":"2013","unstructured":"Esposito S, Purrello SM, Bonnet E, Novelli A, Tripodi F, Pascale R, et al. Central venous catheter-related biofilm infections: an up-to-date focus on meticillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2013;1(2):71\u20138.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"4673_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/femsre\/fux007","volume":"41","author":"TJ Foster","year":"2017","unstructured":"Foster TJ. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017;41(3):430\u201349.","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"4673_CR7","doi-asserted-by":"publisher","first-page":"e0187792","DOI":"10.1371\/journal.pone.0187792","volume":"12","author":"JF Guest","year":"2017","unstructured":"Guest JF, Esteban J, Manganelli AG, Novelli A, Rizzardini G, Serra M. Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: results of a network meta-analysis. PLoS One. 2017;12(11):e0187792.","journal-title":"PLoS One"},{"issue":"7","key":"4673_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.drudis.2022.05.006","volume":"27","author":"J Jampilek","year":"2022","unstructured":"Jampilek J. Drug repurposing to overcome microbial resistance. Drug Discov Today. 2022;27(7):2028\u201341.","journal-title":"Drug Discov Today"},{"issue":"4","key":"4673_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ccc.2013.06.006","volume":"29","author":"E Rubinstein","year":"2013","unstructured":"Rubinstein E, Keynan Y. Vancomycin-resistant enterococci. Crit Care Clin. 2013;29(4):841\u201352.","journal-title":"Crit Care Clin"},{"issue":"1670","key":"4673_CR10","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0082","volume":"370","author":"LJ Shallcross","year":"2015","unstructured":"Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond B Biol Sci. 2015;370(1670):20140082.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"4673_CR11","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT. 2015;40(4):277\u201383.","journal-title":"PT"},{"issue":"6797","key":"4673_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/35021219","volume":"406","author":"C Walsh","year":"2000","unstructured":"Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000;406(6797):775\u201381.","journal-title":"Nature"},{"issue":"2","key":"4673_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5599\/admet.1271","volume":"10","author":"V Gigante","year":"2022","unstructured":"Gigante V, Sati H, Beyer P. Recent advances and challenges in antibacterial drug development. ADMET DMPK. 2022;10(2):147\u201351.","journal-title":"ADMET DMPK"},{"issue":"1","key":"4673_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/CMR.00030-10","volume":"24","author":"LL Silver","year":"2011","unstructured":"Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev. 2011;24(1):71\u2013109.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"4673_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41564-020-0767-0","volume":"5","author":"U Theuretzbacher","year":"2020","unstructured":"Theuretzbacher U. Dual-mechanism antibiotics. Nat Microbiol. 2020;5(8):984\u20135.","journal-title":"Nat Microbiol"},{"issue":"4","key":"4673_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cid\/cir828","volume":"54","author":"RS Daum","year":"2012","unstructured":"Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis. 2012;54(4):560\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4673_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jac\/dku421","volume":"70","author":"RE Mendes","year":"2015","unstructured":"Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13). J Antimicrob Chemother. 2015;70(2):498\u2013504.","journal-title":"J Antimicrob Chemother"},{"key":"4673_CR18","doi-asserted-by":"crossref","unstructured":"Abedon ST. Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy? Antibiot (Basel). 2019;8(4):182.","DOI":"10.3390\/antibiotics8040182"},{"issue":"6","key":"4673_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","volume":"8","author":"BK Chan","year":"2013","unstructured":"Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013;8(6):769\u201383.","journal-title":"Future Microbiol"},{"issue":"9","key":"4673_CR20","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","volume":"42","author":"T Luong","year":"2020","unstructured":"Luong T, Salabarria AC, Roach DR. Phage therapy in the resistance era: where do we stand and where are we going? Clin Ther. 2020;42(9):1659\u201380.","journal-title":"Clin Ther"},{"issue":"1","key":"4673_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","volume":"18","author":"A Coates","year":"2020","unstructured":"Coates A, Hu Y, Holt J, Yeh P. Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Expert Rev Anti-Infect Ther. 2020;18(1):5\u201315.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"8","key":"4673_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/apt.16044","volume":"52","author":"DT Dieterich","year":"2020","unstructured":"Dieterich DT, Bernstein D, Flamm S, Pockros PJ, Reau N. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. Aliment Pharmacol Ther. 2020;52(8):1311\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"4673_CR23","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1007\/s12325-022-02235-w","volume":"39","author":"ME Orme","year":"2022","unstructured":"Orme ME, Bentley R, Marcella S, Peck-Radosavljevic M, Perard R, Wedemeyer H, et al. Systematic review with meta-analysis: efficacy and safety of lusutrombopag for severe thrombocytopenia in patients with chronic liver disease undergoing invasive procedures. Adv Ther. 2022;39(9):4169\u201388.","journal-title":"Adv Ther"},{"issue":"4","key":"4673_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acsinfecdis.3c00737","volume":"10","author":"P She","year":"2024","unstructured":"She P, Li L, Yang Y, Zhou L, Huang G, Xiao D, et al. Lusutrombopag as a repurposing drug in combination with aminoglycosides against Vancomycin-resistant Enterococcus. ACS Infect Dis. 2024;10(4):1327\u201338.","journal-title":"ACS Infect Dis"},{"key":"4673_CR25","unstructured":"CHINET Data. Retrieved 2025\/5\/22 from https:\/\/www.chinets.com\/Data\/AntibioticDrugFast."},{"issue":"10","key":"4673_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13100677","volume":"13","author":"N Ahmad-Mansour","year":"2021","unstructured":"Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne J, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins. 2021;13(10):677.","journal-title":"Toxins"},{"issue":"7","key":"4673_CR27","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1128\/IAI.00394-15","volume":"83","author":"SS Dastgheyb","year":"2015","unstructured":"Dastgheyb SS, Villaruz AE, Le KY, Tan VY, Duong AC, Chatterjee SS, et al. Role of phenol-soluble modulins in formation of Staphylococcus aureus biofilms in synovial fluid. Infect Immun. 2015;83(7):2966\u201375.","journal-title":"Infect Immun"},{"issue":"27","key":"4673_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123385119","volume":"119","author":"H Nakamura","year":"2022","unstructured":"Nakamura H, Hisano T, Rahman MM, Tosha T, Shirouzu M, Shiro Y. Structural basis for heme detoxification by an ATP-binding cassette-type efflux pump in gram-positive pathogenic bacteria. Proc Natl Acad Sci U S A. 2022;119(27):e2123385119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4673_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14168-4","volume":"7","author":"J Geraci","year":"2017","unstructured":"Geraci J, Neubauer S, Pollath C, Hansen U, Rizzo F, Krafft C, et al. The Staphylococcus aureus extracellular matrix protein (Emp) has a fibrous structure and binds to different extracellular matrices. Sci Rep. 2017;7(1):13665.","journal-title":"Sci Rep"},{"issue":"6","key":"4673_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.chom.2021.03.007","volume":"29","author":"M Matsumoto","year":"2021","unstructured":"Matsumoto M, Nakagawa S, Zhang L, Nakamura Y, Villaruz AE, Otto M, et al. Interaction between Staphylococcus Agr virulence and neutrophils regulates pathogen expansion in the skin. Cell Host Microbe. 2021;29(6):930\u201340.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"4673_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003016","volume":"8","author":"T Geiger","year":"2012","unstructured":"Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, et al. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog. 2012;8(11):e1003016.","journal-title":"PLoS Pathog"},{"key":"4673_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1106319","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Xiong Y, Xiao H, Zheng J, Wen Z, Li D, et al. Inhibition of planktonic growth and biofilm formation of Staphylococcus aureus by entrectinib through disrupting the cell membrane. Front Microbiol. 2022;13:1106319.","journal-title":"Front Microbiol"},{"issue":"34","key":"4673_CR33","doi-asserted-by":"publisher","first-page":"20856","DOI":"10.1074\/jbc.M115.659136","volume":"290","author":"H Fan","year":"2015","unstructured":"Fan H, Hahm J, Diggs S, Perry J, Blaha G. Structural and functional analysis of BipA, a regulator of virulence in enteropathogenic Escherichia coli. J Biol Chem. 2015;290(34):20856\u201364.","journal-title":"J Biol Chem"},{"issue":"4","key":"4673_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013047","volume":"21","author":"E Choi","year":"2025","unstructured":"Choi E, Ryu E, Kim D, Byun JW, Kim K, Lee M, et al. The dual functions of the GTPase BipA in ribosome assembly and surface structure biogenesis in Salmonella enterica serovar Typhimurium. PLoS Pathog. 2025;21(4):e1013047.","journal-title":"PLoS Pathog"},{"issue":"1","key":"4673_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2958.1999.01142.x","volume":"31","author":"J Bjorkman","year":"1999","unstructured":"Bjorkman J, Samuelsson P, Andersson DI, Hughes D. Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol. 1999;31(1):53\u20138.","journal-title":"Mol Microbiol"},{"issue":"6","key":"4673_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41589-022-01040-4","volume":"18","author":"K Ortmayr","year":"2022","unstructured":"Ortmayr K, de la Cruz MR, Zampieri M. Expanding the search for small-molecule antibacterials by multidimensional profiling. Nat Chem Biol. 2022;18(6):584\u201395.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"4673_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03377-3","volume":"24","author":"X Liu","year":"2024","unstructured":"Liu X, Xiong Y, Peng R, Zhang Y, Cai S, Deng Q, et al. Antibacterial activity and mechanisms of D-3263 against Staphylococcus aureus. BMC Microbiol. 2024;24(1):224.","journal-title":"BMC Microbiol"},{"issue":"1","key":"4673_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40265-015-0525-4","volume":"76","author":"ES Kim","year":"2016","unstructured":"Kim ES. Lusutrombopag: first global approval. Drugs. 2016;76(1):155\u20138.","journal-title":"Drugs"},{"key":"4673_CR39","unstructured":"EMA. lusutrombopag. In., vol. 2024; 2019. Lusutrombopag Shionogi, INN-lusutrombopag (acess)."},{"issue":"10","key":"4673_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/hepr.13392","volume":"49","author":"R Sasaki","year":"2019","unstructured":"Sasaki R, Shiino C, Imawari M, Bentley R, Cai B, Yoshida M, et al. Safety and effectiveness of Lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: interim results of a postmarketing surveillance. Hepatol Res. 2019;49(10):1169\u201381.","journal-title":"Hepatol Res"},{"issue":"2","key":"4673_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","volume":"54","author":"R Tateishi","year":"2019","unstructured":"Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, et al. A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation. J Gastroenterol. 2019;54(2):171\u201381.","journal-title":"J Gastroenterol"},{"key":"4673_CR42","doi-asserted-by":"crossref","unstructured":"Lyu Z, Wilson C, Ling J. Translational fidelity during bacterial stresses and host interactions. Pathogens. 2023;12(3):383.","DOI":"10.3390\/pathogens12030383"},{"issue":"8060","key":"4673_CR43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41586-025-08723-7","volume":"640","author":"M Jangra","year":"2025","unstructured":"Jangra M, Travin DY, Aleksandrova EV, Kaur M, Darwish L, Koteva K, et al. A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome. Nature (London). 2025;640(8060):1022\u201330.","journal-title":"Nature (London)"},{"issue":"1","key":"4673_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-022-00128-1","volume":"38","author":"P Mukherjee","year":"2022","unstructured":"Mukherjee P, Roy S, Ghosh D, Nandi SK. Role of animal models in biomedical research: a review. Lab Anim Res. 2022;38(1):18.","journal-title":"Lab Anim Res"},{"issue":"3","key":"4673_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/0253-7613.132153","volume":"46","author":"DK Badyal","year":"2014","unstructured":"Badyal DK, Desai C. Animal use in pharmacology education and research: the changing scenario. Indian J Pharmacol. 2014;46(3):257\u201365.","journal-title":"Indian J Pharmacol"},{"issue":"6","key":"4673_CR46","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/acsinfecdis.4c01020","volume":"11","author":"X Liu","year":"2025","unstructured":"Liu X, Li C, Meng Q, Chen C, Lai Y, Wang H, et al. Derazantinib inhibits the planktonic growth and biofilm formation of Staphylococcus aureus by binding membrane phospholipids and disrupting the cell membrane. ACS Infect Dis. 2025;11(6):1473\u201385.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"4673_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-04163-5","volume":"25","author":"X Huang","year":"2025","unstructured":"Huang X, Li C, Zhang C, Xiang Y, Yu Z, Li P, et al. Repurposing etalocib suppresses multidrug-resistant Staphylococcus aureus by disrupting the bacterial membrane. BMC Microbiol. 2025;25(1):472.","journal-title":"BMC Microbiol"},{"key":"4673_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2016.08.027","volume":"52","author":"W Zhao","year":"2016","unstructured":"Zhao W, Zheng M, Wang B, Mu X, Li P, Fu L, et al. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo. Int J Infect Dis. 2016;52:23\u20138.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"4673_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1099\/00222615-45-5-319","volume":"45","author":"K Takashima","year":"1996","unstructured":"Takashima K, Tateda K, Matsumoto T, Ito T, Iizawa Y, Nakao M, et al. Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA\/J mice. J Med Microbiol. 1996;45(5):319\u201322.","journal-title":"J Med Microbiol"},{"issue":"1","key":"4673_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62655-4","volume":"16","author":"CD Jackson-Litteken","year":"2025","unstructured":"Jackson-Litteken CD, Di Venanzio G, Janet-Maitre M, Castro IA, Mackel JJ, Wilson LD, et al. A chronic acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections. Nat Commun. 2025;16(1):7617.","journal-title":"Nat Commun"},{"issue":"4","key":"4673_CR51","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.47836\/pjst.30.4.23","volume":"30","author":"KFRM Diana Lorons","year":"2022","unstructured":"Diana Lorons KFRM. Rna isolation from environmental samples of a harmful algal bloom for metatranscriptome mext-generation sequencing. Pertanika J Sci Technol. 2022;30(4):2707\u201325.","journal-title":"Pertanika J Sci Technol"},{"key":"4673_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1551844","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zeng L, Song G, Peng G, Chen Z, Yuan Y, et al. A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC. Front Immunol. 2025;16:1551844.","journal-title":"Front Immunol"},{"key":"4673_CR53","first-page":"418","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, You Y, Yi L, Wu X, Zhao Y, Yu J, Liu H, Shen Y, Guo J, Huang C. Dental plaque-inspired versatile nanosystem for caries prevention and tooth restoration. Bioact Mater. 2023;20:418\u201333.","journal-title":"Bioact Mater"},{"issue":"8016","key":"4673_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493\u2013500.","journal-title":"Nature"},{"issue":"D1","key":"4673_CR55","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen T, Ma J, Liu Y, Chen Z, Xiao N, Lu Y, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50(D1):D1522\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4673_CR56","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47(D1):D1211\u20137.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04673-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:03:13Z","timestamp":1774022593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4673"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04673-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in compliance with relevant guidelines and regulations, and were approved by the Ethics Committee of Shenzhen Nanshan People\u2019s Hospital, in alignment with the principles of the 1964 Helsinki Declaration and its subsequent amendments. The study adhered to comparable ethical standards. All experimental protocols involving human subjects were reviewed and approved by the institutional ethics committee of Shenzhen Nanshan People\u2019s Hospital. Bacterial strains were obtained as part of standard clinical patient management, following national guidelines in China. As a result, informed consent was not required, and a waiver for informed consent was granted by the institutional ethics committee of Shenzhen Nanshan People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}